Medtronic is facing sluggish sales growth, is in the midst of deep cost-cutting and started ongoing global layoffs in April. It's also spinning off businesses with weaker profit margins.
So med-tech analysts will be watching closely Thursday as the world's largest medical device maker reports its fiscal fourth-quarter results.
Wall Street analysts have predicted a consensus revenue estimate of $8.25 billion for the quarter, a 2% increase over the year-ago period. They predict adjusted earnings per share of $1.56, a 2.6% increase, for Medtronic, which is based in Ireland but run from Fridley, Minnesota.
